Physician profile
Bartosz Maska
NPI 1790238087
$6,217.86
in general payments reported to CMS, 2019-2025
8 companies · $626 in 2025
The $626 reported for 2025 was more than what 92% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $89.56 · 2021: $1,449 · 2022: $2,985 · 2023: $488 · 2024: $217 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $798 · Travel and Lodging: $434 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $797.68 |
| Travel and Lodging | $434.00 |
| Education | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $3,693.87 | 2019-2022 | |
| Zimvie INC. | $1,116.73 | 2022-2025 | |
| Straumann USA LLC | $567.43 | 2019-2024 | |
| Geistlich Pharma, North America, INC. | $251.09 | 2020-2025 | Biomaterials, Geistlich Bio-Gide, Bio-Gide |
| Salvin Dental Specialties, INC. | $223.41 | 2020-2021 | |
| Biohorizons Implant Systems INC. | $210.03 | 2019-2021 | |
| Nobel Biocare USA | $108.13 | 2019-2021 | |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $47.17 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bartosz Maska listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.